Immunotherapy in China typically ranges from $2,800 to $8,500 depending on the protocol and cancer type. Final costs depend on the drug origin, cycle frequency, and hospital tier in cities like Beijing and Guangzhou. Patients save approximately 81% compared to the US, where costs average $30,000. Chinese packages often include advanced diagnostics and minimally invasive support therapies.
- CAR T-cell therapy: Price on request
to Price on request
for advanced hematological treatments.
- Keytruda (Pembrolizumab): $6,200 to $11,500 per session using imported inhibitors.
- Drug choice: Domestic PD-1 inhibitors cost 70-85% less than imported Western brands.
- Biological therapy: $5,800 to $15,500 for targeted immune system enhancement.
Bookimed Expert Insight: Choosing JCI-accredited centers in Guangzhou offers high-value alternatives to standard chemotherapy. Fuda Cancer Hospital provides packages around $4,900 that integrate immunotherapy with NanoKnife and cryosurgery. This multi-modal approach is a smart move for late-stage cases. It often yields better results than monotherapy alone. Hospitals like Lu Daopei in Beijing also offer massive scale with 1,300 beds for specialized hematology care.